Cadila Pharmaceuticals Limited
Manufacturer / marketing-authorisation holder
Cadila Pharmaceuticals Limited — 95 products across 2 markets, 2 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Cadila Pharmaceuticals Limited — 95 productos en 2 mercados, 2 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Cadila Pharmaceuticals Limited —— 共 95 个产品，覆盖 2 个市场、2 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
95 products · 2 markets · 2 brand names
95 productos · 2 mercados · 2 marcas
95 个产品 · 2 个市场 · 2 个品牌名
Products by country
US
Source: api.fda.gov
| Brand | Active ingredient(s) | Form |
|---|---|---|
| — | 阿昔洛韦 | tablet |
| — | 吉非罗齐 | tablet |
| — | 盐酸多奈哌齐 | tablet |
| — | 盐酸文拉法辛 | tablet |
| — | 氟西汀 | capsule |
| — | Nebivolol | tablet |
| — | 盐酸拉贝洛尔 | tablet |
| — | 盐酸文拉法辛 | tablet |
| — | 红霉素 | tablet |
| — | 利斯的明透皮 | capsule |
| — | Hydralazine | tablet |
| — | 盐酸多奈哌齐 | tablet |
| — | 盐酸文拉法辛 | tablet |
| — | 普瑞巴林 | capsule |
| — | 盐酸维拉帕米 | tablet |
| — | 奥氮平 | tablet |
| — | 奥氮平 | tablet |
| — | 奥氮平 | tablet |
| — | 盐酸文拉法辛 | tablet |
| — | 阿托伐他汀 | tablet |
| — | 帕罗西汀 | tablet |
| — | 氧氟沙星 | tablet |
| — | 枸橼酸西地那非 | tablet |
| — | 阿昔洛韦 | capsule |
| — | Glyburide | tablet |
| — | 盐酸文拉法辛 | tablet |
| — | 普瑞巴林 | capsule |
| — | 普瑞巴林 | capsule |
| — | 普瑞巴林 | capsule |
| — | Nebivolol | tablet |
MX
Source: www.gob.mx
Showing the first 32 of 95 products (ordered by country).
Mostrando los primeros 32 de 95 productos (orden por país).
仅显示前 32 / 95 个产品（按国家排序）。